Biotechnology

Filter

Current filters:

None

Popular Filters

20 to 44 of 2470 results

Novogen identifies family of compounds to promote brain stem cell growth

Novogen identifies family of compounds to promote brain stem cell growth

16-01-2015

Australian biotech firm Novogen has announced an important discovery in its regenerative medicine program…

BiotechnologyNeurologicalNovogenResearch

UK NICE recommends hepatitis C drugs Sovaldi and Olysio

UK NICE recommends hepatitis C drugs Sovaldi and Olysio

16-01-2015

In final draft guidance issued today, England health costs watchdog the National Institute for Health…

Anti-viralsBiotechnologyGilead SciencesJanssenJohnson & JohnsonOlysioPricingRegulationSovaldiUK

AstraZeneca unit in deal with Omnis Pharma for oncolytic viruses in immuno-oncology

15-01-2015

Anglo-Swedish pharma major AstraZeneca’s biologics R&D subsidiary MedImmune has entered into a licensing…

AstraZenecaBiotechnologyLicensingMedImmuneOmnis PharmaceuticalsOncology

Low dollar tipped to stimulate biotech investment in Australia

15-01-2015

Analyst commentary suggests the devaluation of the Australian dollar during 2014, has left biotech in…

ActinogenAustraliaBenitec BiopharmaBiotechnologyFinancialMergers & AcquisitionsSirtex Medical

Treeway collaborates with uniQure on gene therapy for ALS

15-01-2015

Netherlands-based biotech firm Treeway has entered into a collaboration with Dutch gene therapy company…

BiotechnologyLicensingNeurologicalResearchTreewayuniQure

New biotech Solvanix launched in Australia with start-up investment from the MRCF

15-01-2015

Solvanix Pty Ltd, an early stage biotechnology company with a novel technology for improving stability…

AustraliaBiotechnologyFinancialResearchSolvanixStAbilize

Gilead denied patent for hepatitis C drug Sovaldi in India

Gilead denied patent for hepatitis C drug Sovaldi in India

15-01-2015

The Indian Patent Controller yesterday rejected one of US biotech major Gilead Sciences’ key patent…

Anti-viralsBiotechnologyGileadIndiaLegalPatentssofosbuvirSovaldi

Seth Elliott appointed president and chief operating officer of Immune Therapeutics

14-01-2015

Immunotherapy specialist Immune Therapeutics has appointed Seth Elliott as president and chief operating…

BiotechnologyBoardroomImmune TherapeuticsImmunologicalsUSA

Celgene exercises option on Agios Pharma’ AG-120

Celgene exercises option on Agios Pharma’ AG-120

14-01-2015

US cancer metabolism specialist Agios Pharmaceuticals says that biotech major Celgene will exercise its…

AG-120Agios PharmaceuticalsBiotechnologyCelgene CorpLicensingOncologyUSA

Aegerion Pharma under SEC investigation

Aegerion Pharma under SEC investigation

14-01-2015

US biotech firm Aegerion Pharmaceuticals has revealed it is the subject of a US Securities and Exchange…

Aegerion PharmaceuticalsBiotechnologyBrazilCardio-vascularJuxtapidLegalMarkets & MarketingRare diseasesUSA

Tekmira to merge with OnCore, to create major hep B company

Tekmira to merge with OnCore, to create major hep B company

14-01-2015

Shares of Tekmira Pharmaceuticals leapt as much as 50% after it announced a merger with privately-held…

Anti-viralsBiotechnologyOnCore BioPharmaOnCore BioPharmaTekmira PharmaceuticalsUSA

Merck & Co inks discovery and development deal with Moderna

Merck & Co inks discovery and development deal with Moderna

13-01-2015

Privately-held Moderna Therapeutics has entered into a license and collaboration agreement with US pharma…

Anti-viralsBiotechnologyFinancialMerck & CoModerna TherapeuticsResearchUSAVaccines

Mersana Therapeutics in up to $300 million deal with Takeda

13-01-2015

Privately-held US biotech company Mersana Therapeutics has expanded its ongoing collaboration with Japan’s…

BiotechnologyLicensingMersana TherapeuticsOncologyTakeda Pharmaceutical

Vedanta collaborates with Janssen on IBD drug candidate VE202

13-01-2015

US microbiome company Vedanta Biosciences has signed a license agreement with Janssen Biotech for Vedanta's…

BiotechnologyGastro-intestinalsJanssen BiotechJohnson & JohnsonLicensingResearchVE202Vedanta Biosciences

Amgen to collaborate with University of Texas on BiTE technology

Amgen to collaborate with University of Texas on BiTE technology

13-01-2015

US biotech major Amgen is to collaborate with the MD Anderson Cancer Center at the University of Texas…

AmgenBiotechnologyOncologyResearchUSA

Harvoni scores another victory with inclusion on Prime’s preferred list

Harvoni scores another victory with inclusion on Prime’s preferred list

13-01-2015

US pharmacy Prime Therapeutics has agreed to provide hepatitis C drug Harvoni (ledipasvir/sofosbuvir)…

Antibiotics and Infectious diseasesBiotechnologyGileadHarvoniPricingUSA

Cost to NHS of Provenge too high to be recommended, says NICE

13-01-2015

England’s health care cost watchdog the National Institute for Health and Care Excellence (NICE) has…

BiotechnologyDendreonOncologyPricingProvengeRegulationUK

Hospira submits new BLA for epoetin alfa biosimilar In USA

12-01-2015

US injectable drugs and infusion technologies and biosimilars developer Hospira has submitted a Biologics…

AmgenBiosimilarsBiotechnologyepoetinEpogenHematologyHospiraJanssenJohnson & JohnsonProcritRegulationRetacritUSA

EMA accepts Sanofi and Regeneron's MMA for Praluent for review

EMA accepts Sanofi and Regeneron's MMA for Praluent for review

12-01-2015

French drug major Sanofi and US biotech company Regeneron have announced that the European Medicines…

alirocumabBiotechnologyCardio-vascularEuropeRegeneronRegulationSanofi

Qiagen acquires unit of Enzymatics and agrees partnership with ArcherDX

Qiagen acquires unit of Enzymatics and agrees partnership with ArcherDX

12-01-2015

Netherlands-based company Qiagen has acquired the Enzyme Solutions Unit of privately-held US company…

ArcherDXBiotechnologyEnzymaticsGeneticsMergers & AcquisitionsNetherlandsQiagen

China’s FDA approves Chipscreen’s Epidaza

China’s FDA approves Chipscreen’s Epidaza

12-01-2015

Chinese biotech firm Chipscreen Biosciences has received regulatory approval of Epidaza (chidamide),…

BiotechnologychidamideChinaChipscreen BiosciencesEpidazaOncologyRegulation

Shire to spend $5.2 billion to buy NPS Pharma

Shire to spend $5.2 billion to buy NPS Pharma

12-01-2015

Recently jilted Ireland-headquartered Shire says it is to acquire NPS Pharmaceuticals, confirming recent…

BiotechnologyEuropeGattexMergers & AcquisitionsNatparaNPS PharmaceuticalsRare diseasesRevestiveShire

20 to 44 of 2470 results

Back to top